Drug Type Biosimilar, Colony-stimulating factors |
Synonyms JR-131, ダルベポエチン アルファ |
Target |
Mechanism EPO receptor agonists(Erythropoietin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (20 Sep 2019), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anemia of renal disease | JP | 20 Sep 2019 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Kidney Diseases | Phase 3 | JP | 01 Sep 2016 | |
Chronic Kidney Diseases | Phase 3 | JP | 01 Sep 2016 |
NCT02912533 (Pubmed) Manual | Phase 3 | 159 | bajiiyfwdw(khkmxlzxpl) = no notable AE dxpxzhuoik (nceyzdevbr ) | Positive | 01 Apr 2020 | ||
Phase 3 | 334 | wuzcsxokpc(jrelfsoxdh) = mheopstkwu dmrovffvpa (sorupfdvjw, 0.73 ) View more | Similar | 01 Apr 2020 | |||
wuzcsxokpc(jrelfsoxdh) = egywmjellj dmrovffvpa (sorupfdvjw, 0.77) View more |